BiOptix Selected By Australian Customer

Boulder's BiOptix>, which develops sensors used for biomolecular analysis, reported a win this morning in Australia, with the Garvan Institute of Medical Research. BiOptix said that Garvan has selected its BiOptix 404pi for their drug discovery research. Financial impact of the win was not announced. The company said its equipment will be used in stability engineering of human antibody reagents for therapeutic purposes. BiOptix is led by Rick Whitcomb.